 Well, I've heard a lot about buffer inventory strategies after shortages, but we had them all before the shortages affect these molecules. So everyone had a buffer. We plowed right through it and distributed it before the allocations came into effect. So I think a lot about checks and balances. If there are buffers at the manufacturer level, how they get to the distributor level and then how they get to the purchasers is really what this is about.